Advances in Dermoscopy for Melanoma and Non-Melanoma Skin Cancer

Dear Colleagues,

Dermoscopy has become a cornerstone in the diagnosis and management of melanoma and non-melanoma skin cancers, with clear evidence that it improves diagnostic accuracy and facilitates earlier detection. Current advances are extending its utility: refined diagnostic criteria, site-specific adaptations for challenging anatomic regions, and integration with non-invasive imaging methods such as reflectance confocal microscopy and optical coherence tomography. The rapid development of artificial intelligence and the increasing use of teledermoscopy and smartphone-based tools are also reshaping how dermoscopy is practiced and accessed.

This Special Issue will provide an up-to-date synthesis of these developments, emphasizing their relevance to clinical care and their role in the evolving landscape of skin cancer diagnosis.

Proposed Chapter Topics

1. Dermoscopy for Melanoma—current diagnostic criteria, emerging features, and the role of digital monitoring in early detection.
2. Dermoscopy for Non-Melanoma Skin Cancers—characteristic patterns in basal cell carcinoma, squamous cell carcinoma, and related variants.
3. Site-Specific Dermoscopy—adaptations for acral, facial, mucosal, and nail unit lesions where morphology differs from conventional patterns.
4. Multimodal Imaging Integration—the combined use of dermoscopy with reflectance confocal microscopy, optical coherence tomography, teledermoscopy, and smartphone-based tools.
5. Dermoscopy and Artificial Intelligence—advances in AI for dermoscopic image analysis and implications for clinical workflows and access to care.

Prof. Dr. Clay J. Cockerell
Dr. Warren Chan
Dr. Jade Conway
Dr. Iman Ali
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.